1
|
Richard GF, Kerrest A and Dujon B:
Comparative genomics and molecular dynamics of DNA repeats in
eukaryotes. Microbiol Mol Biol Rev. 72:686–727. 2008. View Article : Google Scholar
|
2
|
Lynch HT, Shaw MW, Magnuson CW, Larsen AL
and Krush AJ: Hereditary factors in cancer. Study of two large
midwestern kindreds. Arch Intern Med. 117:206–212. 1966. View Article : Google Scholar
|
3
|
Dean DA, Wadl PA, Hadziabdic D, Wang X and
Trigiano RN: Analyzing microsatellites using the QIAxcel system.
Methods Mol Biol. 1006:223–243. 2013. View Article : Google Scholar
|
4
|
Li K, Luo H, Huang L, Luo H and Zhu X:
Microsatellite instability: A review of what the oncologist should
know. Cancer Cell Int. 20:162020. View Article : Google Scholar
|
5
|
Fan H and Chu JY: A brief review of short
tandem repeat mutation. Genomics Proteomics Bioinformatics. 5:7–14.
2007. View Article : Google Scholar
|
6
|
Roudko V, Cimen Bozkus C, Greenbaum B,
Lucas A, Samstein R and Bhardwaj N: Lynch Syndrome and MSI-H
Cancers: From Mechanisms to ‘Off-The-Shelf’ Cancer Vaccines. Front
Immunol. 12:7578042021. View Article : Google Scholar
|
7
|
Reyes GX, Schmidt TT, Kolodner RD and
Hombauer H: New insights into the mechanism of DNA mismatch repair.
Chromosoma. 124:443–462. 2015. View Article : Google Scholar
|
8
|
Tamura K, Kaneda M, Futagawa M, Takeshita
M, Kim S, Nakama M, Kawashita N and Tatsumi-Miyajima J: Genetic and
genomic basis of the mismatch repair system involved in Lynch
syndrome. Int J Clin Oncol. 24:999–1011. 2019. View Article : Google Scholar
|
9
|
Hause RJ, Pritchard CC, Shendure J and
Salipante SJ: Classification and characterization of microsatellite
instability across 18 cancer types. Nat Med. 22:1342–1350. 2016.
View Article : Google Scholar
|
10
|
Le DT, Uram JN, Wang H, Bartlett BR,
Kemberling H, Eyring AD, Skora AD, Luber BS, Azad NS, Laheru D, et
al: PD-1 blockade in tumors with mismatch-repair deficiency. N Engl
J Med. 372:2509–2520. 2015. View Article : Google Scholar
|
11
|
McMeekin DS, Tritchler DL, Cohn DE, Mutch
DG, Lankes HA, Geller MA, Powell MA, Backes FJ, Landrum LM, Zaino
R, et al: Clinicopathologic significance of mismatch repair defects
in endometrial cancer: An NRG Oncology/Gynecologic oncology group
study. J Clin Oncol. 34:3062–3068. 2016. View Article : Google Scholar
|
12
|
Bonneville R, Krook MA, Kautto EA, Miya J,
Wing MR, Chen HZ, Reeser JW, Yu L and Roychowdhury S: Landscape of
microsatellite instability across 39 cancer types. JCO Precis
Oncol. 2017.PO.17.00073, 2017. View Article : Google Scholar
|
13
|
Green AK, Feinberg J and Makker V: A
Review of immune checkpoint blockade therapy in endometrial cancer.
Am Soc Clin Oncol Educ Book. 40:1–7. 2020.
|
14
|
Boland CR and Goel A: Microsatellite
instability in colorectal cancer. Gastroenterology.
138:2073–2087.e3. 2010. View Article : Google Scholar
|
15
|
Petrelli F, Ghidini M, Cabiddu M, Pezzica
E, Corti D, Turati L, Costanzo A, Varricchio A, Ghidini A, Barni S,
et al: Microsatellite instability and survival in stage ii
colorectal cancer: A systematic review and meta-analysis.
Anticancer Res. 39:6431–6441. 2019. View Article : Google Scholar
|
16
|
Lin A, Zhang J and Luo P: Crosstalk
Between the MSI status and tumor microenvironment in colorectal
cancer. Front Immunol. 11:20392020. View Article : Google Scholar
|
17
|
Makker V, Colombo N, Casado Herraez A,
Santin AD, Colomba E, Miller DS, Fujiwara K, Pignata S, Baron-Hay
S, Ray-Coquard I, et al: Lenvatinib plus Pembrolizumab for advanced
endometrial cancer. N Engl J Med. 386:437–448. 2022. View Article : Google Scholar
|
18
|
Le DT, Durham JN, Smith KN, Wang H,
Bartlett BR, Aulakh LK, Lu S, Kemberling H, Wilt C, Luber BS, et
al: Mismatch repair deficiency predicts response of solid tumors to
PD-1 blockade. Science. 357:409–413. 2017. View Article : Google Scholar
|
19
|
Lenz HJ, Van Cutsem E, Luisa Limon M, Wong
KYM, Hendlisz A, Aglietta M, Garcia-Alfonso P, Neyns B, Luppi G,
Cardin DB, et al: First-Line nivolumab plus Low-Dose ipilimumab for
microsatellite Instability-High/Mismatch repair-deficient
metastatic colorectal cancer: The phase II CheckMate 142 study. J
Clin Oncol. 40:161–170. 2022. View Article : Google Scholar
|
20
|
Green AK, Feinberg J and Makker V: A
review of immune checkpoint blockade therapy in endometrial cancer.
Am Soc Clin Oncol Educ Book. 40:1–7. 2020.
|
21
|
Narayanan S, Kawaguchi T, Peng X, Qi Q,
Liu S, Yan L and Takabe K: Tumor infiltrating lymphocytes and
macrophages improve survival in microsatellite unstable colorectal
cancer. Sci Rep. 9:134552019. View Article : Google Scholar
|
22
|
Diao Z, Han Y, Chen Y, Zhang R and Li J:
The clinical utility of microsatellite instability in colorectal
cancer. Crit Rev Oncol Hematol. 157:1031712021. View Article : Google Scholar
|
23
|
Pal A, Greenblatt HM and Levy Y:
Prerecognition diffusion mechanism of human DNA mismatch repair
proteins along DNA: Msh2-Msh3 versus Msh2-Msh6. Biochemistry.
59:4822–4832. 2020. View Article : Google Scholar
|
24
|
Marsischky GT, Filosi N, Kane MF and
Kolodner R: Redundancy of saccharomyces cerevisiae MSH3 and MSH6 in
MSH2-dependent mismatch repair. Genes Dev. 10:407–420. 1996.
View Article : Google Scholar
|
25
|
Hewish M, Lord CJ, Martin SA, Cunningham D
and Ashworth A: Mismatch repair deficient colorectal cancer in the
era of personalized treatment. Nat Rev Clin Oncol. 7:197–208. 2010.
View Article : Google Scholar
|
26
|
Luchini C, Bibeau F, Ligtenberg MJL, Singh
N, Nottegar A, Bosse T, Miller R, Riaz N, Douillard JY, Andre F, et
al: ESMO recommendations on microsatellite instability testing for
immunotherapy in cancer, and its relationship with PD-1/PD-L1
expression and tumour mutational burden: A systematic review-based
approach. Ann Oncol. 30:1232–1243. 2019. View Article : Google Scholar
|
27
|
Benson AB, Venook AP, Al-Hawary MM, Arain
MA, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D, Farkas L, et
al: Colon cancer, version 2.2021, NCCN clinical practice guidelines
in oncology. J Natl Compr Canc Netw. 19:329–359. 2021. View Article : Google Scholar
|
28
|
Funkhouser WK Jr, Lubin IM, Monzon FA,
Zehnbauer BA, Evans JP, Ogino S and Nowak JA: Relevance,
pathogenesis, and testing algorithm for mismatch repair-defective
colorectal carcinomas: A report of the association for molecular
pathology. J Mol Diagn. 14:91–103. 2012. View Article : Google Scholar
|
29
|
Cicek MS, Lindor NM, Gallinger S, Bapat B,
Hopper JL, Jenkins MA, Young J, Buchanan D, Walsh MD, Le Marchand
L, et al: Quality assessment and correlation of microsatellite
instability and immunohistochemical markers among population- and
clinic-based colorectal tumors results from the colon cancer family
registry. J Mol Diagn. 13:271–281. 2011. View Article : Google Scholar
|
30
|
Hechtman JF, Rana S, Middha S, Stadler ZK,
Latham A, Benayed R, Soslow R, Ladanyi M, Yaeger R, Zehir A, et al:
Retained mismatch repair protein expression occurs in approximately
6% of microsatellite instability-high cancers and is associated
with missense mutations in mismatch repair genes. Mod Pathol.
33:871–879. 2020. View Article : Google Scholar
|
31
|
Cohen R, Hain E, Buhard O, Guilloux A,
Bardier A, Kaci R, Bertheau P, Renaud F, Bibeau F, Flejou JF, et
al: Association of primary resistance to immune checkpoint
inhibitors in metastatic colorectal cancer with misdiagnosis of
microsatellite instability or mismatch repair deficiency status.
JAMA Oncol. 5:551–555. 2019. View Article : Google Scholar
|
32
|
Huang W, Ho CL, Lee CT, Chen WL, Yang SC,
Chow NH and Chen YL: High concordance rate of capillary
electrophoresis workflow for microsatellite instability analysis
and mismatch repair (MMR) immunostaining in colorectal carcinoma.
PLoS One. 18:e02842272023. View Article : Google Scholar
|
33
|
Murphy KM, Zhang S, Geiger T, Hafez MJ,
Bacher J, Berg KD and Eshleman JR: Comparison of the microsatellite
instability analysis system and the Bethesda panel for the
determination of microsatellite instability in colorectal cancers.
J Mol Diagn. 8:305–311. 2006. View Article : Google Scholar
|
34
|
Vikas P, Messersmith H, Compton C, Sholl
L, Broaddus RR, Davis A, Estevez-Diz M, Garje R, Konstantinopoulos
PA, Leiser A, et al: Mismatch repair and microsatellite instability
testing for immune checkpoint inhibitor therapy: ASCO endorsement
of college of american pathologists guideline. J Clin Oncol.
41:1943–1948. 2023. View Article : Google Scholar
|
35
|
Taieb J, Svrcek M, Cohen R, Basile D,
Tougeron D and Phelip JM: Deficient mismatch repair/microsatellite
unstable colorectal cancer: Diagnosis, prognosis and treatment. Eur
J Cancer. 175:136–157. 2022. View Article : Google Scholar
|
36
|
Rodriguez-Bigas MA, Boland CR, Hamilton
SR, Henson DE, Jass JR, Khan PM, Lynch H, Perucho M, Smyrk T, Sobin
L, et al: A National cancer institute workshop on hereditary
nonpolyposis colorectal cancer syndrome: Meeting highlights and
Bethesda guidelines. J Natl Cancer Inst. 89:1758–1762. 1997.
View Article : Google Scholar
|
37
|
Umar A, Boland CR, Terdiman JP, Syngal S,
de la Chapelle A, Rüschoff J, Fishel R, Lindor NM, Burgart LJ,
Hamelin R, et al: Revised Bethesda Guidelines for hereditary
nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite
instability. J Natl Cancer Inst. 96:261–268. 2004. View Article : Google Scholar
|
38
|
Bacher JW, Flanagan LA, Smalley RL, Nassif
NA, Burgart LJ, Halberg RB, Megid WM and Thibodeau SN: Development
of a fluorescent multiplex assay for detection of MSI-High tumors.
Dis Markers. 20:237–250. 2004. View Article : Google Scholar
|
39
|
Goel A, Nagasaka T, Hamelin R and Boland
CR: An optimized pentaplex PCR for detecting DNA mismatch
repair-deficient colorectal cancers. PLoS One. 5:e93932010.
View Article : Google Scholar
|
40
|
Wang Y, Shi C, Eisenberg R and
Vnencak-Jones CL: Differences in microsatellite instability
profiles between endometrioid and colorectal cancers: A potential
cause for False-Negative results? J Mol Diagn. 19:57–64. 2017.
View Article : Google Scholar
|
41
|
Do H and Dobrovic A: Sequence artifacts in
DNA from formalin-fixed tissues: Causes and strategies for
minimization. Clin Chem. 61:64–71. 2015. View Article : Google Scholar
|
42
|
McDonough SJ, Bhagwate A, Sun Z, Wang C,
Zschunke M, Gorman JA, Kopp KJ and Cunningham JM: Use of
FFPE-derived DNA in next generation sequencing: DNA extraction
methods. PLoS One. 14:e02114002019. View Article : Google Scholar
|
43
|
Wu S, Liu X, Wang J, Zhou W, Guan M, Liu
Y, Pang J, Lu T, Zhou L, Shi X, et al: DNA Mismatch repair
deficiency detection in colorectal cancer by a new microsatellite
instability analysis system. Interdiscip Sci. 12:145–154. 2020.
View Article : Google Scholar
|
44
|
Amin MB, Greene FL, Edge SB, Compton CC,
Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR and
Winchester DP: The eighth edition AJCC cancer staging manual:
Continuing to build a bridge from a population-based to a more
‘personalized’ approach to cancer staging. CA Cancer J Clin.
67:93–99. 2017. View Article : Google Scholar
|
45
|
Lee CT, Chow NH, Chen YL, Ho CL, Yeh YM,
Lin SC, Lin PC, Lin BW, Chu CA, Tsai HW, et al: Clinicopathological
features of mismatch repair protein expression patterns in
colorectal cancer. Pathol Res Pract. 217:1532882021. View Article : Google Scholar
|
46
|
O'Leary NA, Wright MW, Brister JR, Ciufo
S, Haddad D, McVeigh R, Rajput B, Robbertse B, Smith-White B,
Ako-Adjei D, et al: Reference sequence (RefSeq) database at NCBI:
Current status, taxonomic expansion, and functional annotation.
Nucleic Acids Res. 44:D733–D745. 2016. View Article : Google Scholar
|
47
|
Ye J, Coulouris G, Zaretskaya I,
Cutcutache I, Rozen S and Madden TL: Primer-BLAST: A tool to design
target-specific primers for polymerase chain reaction. BMC
Bioinformatics. 13:1342012. View Article : Google Scholar
|
48
|
Akoglu H: User's guide to sample size
estimation in diagnostic accuracy studies. Turk J Emerg Med.
22:177–185. 2022. View Article : Google Scholar
|
49
|
Yu F, Makrigiorgos A, Leong KW and
Makrigiorgos GM: Sensitive detection of microsatellite instability
in tissues and liquid biopsies: Recent developments and updates.
Comput Struct Biotechnol J. 19:4931–4940. 2021. View Article : Google Scholar
|
50
|
Liu HX, Zhou XL, Liu T, Werelius B,
Lindmark G, Dahl N and Lindblom A: The role of hMLH3 in familial
colorectal cancer. Cancer Res. 63:1894–1899. 2003.
|
51
|
Kawakami H, Zaanan A and Sinicrope FA:
Microsatellite instability testing and its role in the management
of colorectal cancer. Curr Treat Options Oncol. 16:302015.
View Article : Google Scholar
|
52
|
Jaffrelot M, Farés N, Brunac AC, Laurenty
AP, Danjoux M, Grand D, Icher S, Meilleroux J, Mery E, Buscail E,
et al: An unusual phenotype occurs in 15% of mismatch
repair-deficient tumors and is associated with non-colorectal
cancers and genetic syndromes. Mod Pathol. 35:427–437. 2022.
View Article : Google Scholar
|
53
|
Wang C, Zhang L, Vakiani E and Shia J:
Detecting mismatch repair deficiency in solid neoplasms:
Immunohistochemistry, microsatellite instability, or both? Mod
Pathol. 35:1515–1528. 2022. View Article : Google Scholar
|
54
|
Bao F, Panarelli NC, Rennert H, Sherr DL
and Yantiss RK: Neoadjuvant therapy induces loss of MSH6 expression
in colorectal carcinoma. Am J Surg Pathol. 34:1798–1804. 2010.
View Article : Google Scholar
|
55
|
Kuan SF, Ren B, Brand R, Dudley B and Pai
RK: Neoadjuvant therapy in microsatellite-stable colorectal
carcinoma induces concomitant loss of MSH6 and Ki-67 expression.
Hum Pathol. 63:33–39. 2017. View Article : Google Scholar
|
56
|
Guyot D'Asnières De Salins A, Tachon G,
Cohen R, Karayan-Tapon L, Junca A, Frouin E, Godet J, Evrard C,
Randrian V, Duval A, et al: Discordance between immunochemistry of
mismatch repair proteins and molecular testing of microsatellite
instability in colorectal cancer. ESMO Open. 6:1001202021.
View Article : Google Scholar
|
57
|
Bacher JW, Sievers CK, Albrecht DM, Grimes
IC, Weiss JM, Matkowskyj KA, Agni RM, Vyazunova I, Clipson L,
Storts DR, et al: Improved detection of microsatellite instability
in early colorectal lesions. PLoS One. 10:e01327272015. View Article : Google Scholar
|
58
|
Lin JH, Chen S, Pallavajjala A, Guedes LB,
Lotan TL, Bacher JW and Eshleman JR: Validation of long
mononucleotide repeat markers for detection of microsatellite
instability. J Mol Diagn. 24:144–157. 2022. View Article : Google Scholar
|
59
|
Turner EH, Dickerson JA, Ramsay LM,
Swearingen KE, Wojcik R and Dovichi NJ: Reaction of fluorogenic
reagents with proteins III. Spectroscopic and electrophoretic
behavior of proteins labeled with Chromeo P503. J Chromatogr A.
1194:253–256. 2008. View Article : Google Scholar
|
60
|
Zwaenepoel K, Holmgaard Duelund J, De
Winne K, Maes V, Weyn C, Lambin S, Dendooven R, Broeckx G,
Steiniche T and Pauwels P: Clinical performance of the idylla MSI
test for a rapid assessment of the DNA microsatellite status in
human colorectal cancer. J Mol Diagn. 22:386–395. 2020. View Article : Google Scholar
|
61
|
Siemanowski J, Schomig-Markiefka B, Buhl
T, Haak A, Siebolts U, Dietmaier W, Arens N, Pauly N, Ataseven B,
Buttner R, et al: Managing difficulties of microsatellite
instability testing in endometrial Cancer-Limitations and
advantages of four different PCR-Based approaches. Cancers (Basel).
13:12682021. View Article : Google Scholar
|
62
|
Cancer Genome Atlas Research Network, .
Comprehensive molecular characterization of gastric adenocarcinoma.
Nature. 513:202–209. 2014. View Article : Google Scholar
|